for the Period Ended 31 October 2024
| Directors report | |
| Profit and loss | |
| Balance sheet | |
| Additional notes | |
| Balance sheet notes | |
| Community Interest Report |
Directors' report period ended
The directors present their report with the financial statements of the company for the period ended 31 October 2024
Principal activities of the company
Directors
The director shown below has held office during the period of
31 October 2023
to
31 October 2024
The directors shown below have held office during the whole of the period from
25 October 2023
to
31 October 2024
The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006
This report was approved by the board of directors on
And signed on behalf of the board by:
Name:
Status: Director
for the Period Ended
| 2024 | ||
|---|---|---|
|
|
£ |
|
| Turnover: |
|
|
| Gross profit(or loss): |
|
|
| Administrative expenses: |
(
|
|
| Other operating income: |
|
|
| Operating profit(or loss): |
|
|
| Profit(or loss) before tax: |
|
|
| Profit(or loss) for the financial year: |
|
As at
| Notes | 2024 | ||
|---|---|---|---|
|
|
£ |
||
| Fixed assets | |||
| Tangible assets: | 3 |
|
|
| Total fixed assets: |
|
||
| Current assets | |||
| Debtors: | 4 |
|
|
| Cash at bank and in hand: |
|
||
| Total current assets: |
|
||
| Creditors: amounts falling due within one year: | 5 |
(
|
|
| Net current assets (liabilities): |
|
||
| Total assets less current liabilities: |
|
||
| Provision for liabilities: |
(
|
||
| Accruals and deferred income: |
(
|
||
| Total net assets (liabilities): |
|
||
| Members' funds | |||
| Profit and loss account: |
|
||
| Total members' funds: |
|
The notes form part of these financial statements
This report was approved by the board of directors on
and signed on behalf of the board by:
Name:
Status: Director
The notes form part of these financial statements
for the Period Ended 31 October 2024
Basis of measurement and preparation
Turnover policy
Tangible fixed assets depreciation policy
Other accounting policies
for the Period Ended 31 October 2024
| 2024 | ||
|---|---|---|
| Average number of employees during the period |
|
for the Period Ended 31 October 2024
| Land & buildings | Plant & machinery | Fixtures & fittings | Office equipment | Motor vehicles | Total | |
|---|---|---|---|---|---|---|
| Cost | £ | £ | £ | £ | £ | £ |
| Additions |
|
|
||||
| Disposals | ||||||
| Revaluations | ||||||
| Transfers | ||||||
| At 31 October 2024 |
|
|
||||
| Depreciation | ||||||
| Charge for year |
|
|
||||
| On disposals | ||||||
| Other adjustments | ||||||
| At 31 October 2024 |
|
|
||||
| Net book value | ||||||
| At 31 October 2024 |
|
|
for the Period Ended 31 October 2024
| 2024 | ||
|---|---|---|
| £ | ||
| Trade debtors |
|
|
| Total |
|
for the Period Ended 31 October 2024
| 2024 | ||
|---|---|---|
| £ | ||
| Trade creditors |
|
|
| Other creditors |
|
|
| Total |
|
Vocal Collective create opportunities for people to contribute to health research through patient and public involvement and engagement (PPIE). The company’s activities provide benefit by patients, communities and carers to express their lived expertise and experiences in health and health research. The company also brings benefit to researchers, healthcare practitioners and wider society by supporting research and health care that is inclusive and relevant. This period covers the first year that Vocal Collective has been in existence. It has partnered on one project (Centres for Exchange), and led a second project (Engaged Research Skills and Tools), both funded by the Wellcome Trust and both bringing benefit: The Centres for Exchange is a collaborative learning and design project which develops capacity and innovation in equitable and inclusive health research by supporting community organisations in Kenya, South Africa and India to upskill themselves in research methods and knowledge production. The Engaged Research Skills and Tools project is a research and learning project to support Wellcome researchers to develop their capacity in carrying out open, ethical and engaged research. Ultimately, it will produce a learning journey and repository of resources (project is ongoing). We have also developed a basic website and LinkedIn presence, which will be further developed.
Stakeholders for Vocal Collective include: healthcare and health research organisations, pharmaceutical and life science industries, higher education institutions, funders and policy partners; VCFSE and patient organisations, and individual patients and community partners. This year, consultation with stakeholders has primarily occurred through the successful tendering and delivery of the projects in Part 1, together with ongoing business development. Notably, stakeholders include: Wellcome Trust, UK Research & Innovation, Science Foundation Ireland (Research Ireland), National Institute of Health Research, Manchester University NHS Foundation Trust, Ada Lovelace Foundation; Pivot Collective, Science Ceilidh, Mabadiliko, Restless Development.
No remuneration was received
No transfer of assets other than for full consideration
This report was approved by the board of directors on
24 July 2025
And signed on behalf of the board by:
Name: Mr Mark Claydon
Status: Director